BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith E, Tomita Y, Palethorpe HM, Howell S, Nakhjavani M, Townsend AR, Price TJ, Young JP, Hardingham JE. Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation. Epigenetics 2019;14:158-70. [PMID: 30739527 DOI: 10.1080/15592294.2019.1580112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Patatian A, Delestre-Delacour C, Percoco G, Ramdani Y, Di Giovanni M, Peno-Mazzarino L, Bader T, Bénard M, Driouich A, Lati E, Benech P, Follet-Gueye ML. Skin biological responses to urban pollution in an ex vivo model. Toxicol Lett 2021;348:85-96. [PMID: 34044057 DOI: 10.1016/j.toxlet.2021.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kirana C, Smith E, Ngo DT, Trochsler MI, Hewett PJ, Stubbs RS, Hardingham JE, Maddern GJ, Hauben E. High preoperative levels of circulating SFRP5 predict better prognosis in colorectal cancer patients. Future Oncol 2020;16:2499-509. [PMID: 33048585 DOI: 10.2217/fon-2020-0356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Chow PH, Bowen J, Yool AJ. Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers. Cancers (Basel) 2020;12:E1911. [PMID: 32679804 DOI: 10.3390/cancers12071911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
4 Zhang G, Ma W, Dong H, Shu J, Hou W, Guo Y, Wang M, Wei X, Ren J, Zhang J. Based on Histogram Analysis: ADCaqp Derived from Ultra-high b-Value DWI could be a Non-invasive Specific Biomarker for Rectal Cancer Prognosis. Sci Rep 2020;10:10158. [PMID: 32576929 DOI: 10.1038/s41598-020-67263-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shi Y, Wei J, Chen Z, Yuan Y, Li X, Zhang Y, Meng Y, Hu Y, Du H. Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer. Biomed Res Int 2019;2019:6706354. [PMID: 31828117 DOI: 10.1155/2019/6706354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nakhjavani M, Hardingham JE, Palethorpe HM, Price TJ, Townsend AR. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer. J Breast Cancer 2019;22:341-61. [PMID: 31598336 DOI: 10.4048/jbc.2019.22.e39] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
7 Nakhjavani M, Palethorpe HM, Tomita Y, Smith E, Price TJ, Yool AJ, Pei JV, Townsend AR, Hardingham JE. Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models. Pharmaceuticals (Basel) 2019;12:E117. [PMID: 31374984 DOI: 10.3390/ph12030117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]